CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: BIO 2016 (619) Pharma Startups (6570)
Novellus is a precision oncology company that has developed a live-cell based assay to monitor the activity of signaling pathways. Using this platform, Novellus' solution helps biopharma companies identify new target mutations and expanded subgroups ...Show all
Company (Alive / Active)
Phone:
Hadassah Medical Center Campus
Jerusalem Bio-Park, 5th Floor
Jerusalem, 91120
Israel
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Methods and systems for identifying patient specific driver mutations | Jul 11, 2018 | Oct 27, 2020 | Patent |
| Methods for determining drug response of patient specific mutations | Jul 20, 2015 | Feb 04, 2020 | Patent |
| Methods and systems for identifying patient specific driver mutations | Jan 16, 2014 | Aug 14, 2018 | Patent |
| Systems, devices, kits and methods for indirect transfection of multiple sets of nucleic-acids and transfer of molecules | Dec 15, 2015 | Application | |
| Systems, devices, kits and methods for seeding cells or sets of molecules in an array on a substrate | Dec 15, 2015 | Application |
